Eton Pharmaceutical ETON
$60.85 −$0.51 (-0.83%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $60.85 0.00%
Open$61.00
Prev close$61.36
Day range$59.18 – $61.65
Volume562.7K
Market cap$1.76B
P/E (TTM)39.5
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$57.93M+157.9% YoY
Operating profit$23.01M+1,788.4% YoY
Net profit$35.25M+1,929.2% YoY
Diluted EPS$1.06+1,614.3% YoY
Free cash flow$32.00M+172.6% YoY
Operating cash flow$35.24M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin69.2%
Operating margin28.8%
Net margin35.3%
Return on equity90.6%
Return on assets38.1%
Return on invested capital60.4%
Current ratio1.79
Liabilities / assets44.7%
Cash & investments$55.63M
Total debt$24.09M
Net cash (debt)$31.54M
Free cash flow / sales14.2%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $57.93M | $37.59M | $24.27M | $79.95M | $21.28M |
| Total Operating Revenue | $57.93M | $37.59M | $24.27M | $79.95M | $21.28M |
| Cost of Revenue | $13.62M | $12.18M | $9.53M | $37.21M | $8.18M |
| Gross Profit | $44.30M | $25.41M | $14.74M | $42.74M | $13.10M |
| Operating Expense | $21.29M | $12.62M | $12.32M | $43.58M | $10.64M |
| Selling and Admin Expenses | $16.02M | $11.63M | $10.45M | $35.82M | $8.86M |
| -General & Admin Expense | $16.02M | $11.63M | $10.45M | $35.82M | $8.86M |
| Research & Development | $5.27M | $993,000.00 | $1.88M | $7.77M | $1.78M |
| Operating Profit | $23.01M | $12.79M | $2.41M | -$844,000.00 | $2.46M |
| Net Non-Operating Interest Income (Expense) | -$656,000.00 | -$1.08M | -$840,000.00 | -$3.71M | -$1.05M |
| Non-Operating Interest Expense | $656,000.00 | $1.08M | $840,000.00 | – | – |
| Pretax Profit | $22.36M | $11.72M | $1.57M | -$4.56M | $1.41M |
| Tax | -$12.89M | $140,000.00 | $20,000.00 | $43,000.00 | -$69,000.00 |
| Net Profit | $35.25M | $11.58M | $1.55M | -$4.60M | $1.48M |
| Profit from Continuing Operations | $35.25M | $11.58M | $1.55M | -$4.60M | $1.48M |
| Net Income to Parent Company | $35.25M | $11.58M | $1.55M | -$4.60M | $1.48M |
| Net Income to Common Stockholders | $35.25M | $11.58M | $1.55M | -$4.60M | $1.48M |
| Basic EPS | $1.23 | $0.42 | $0.06 | -$0.17 | $0.06 |
| Diluted EPS | $1.06 | $0.35 | $0.05 | -$0.17 | $0.05 |
| Total Other Finance Costs | – | – | – | $3.71M | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $157.27M | $115.81M | $97.71M | $92.11M | $92.11M |
| Total Current Assets | $96.78M | $68.60M | $53.25M | $60.58M | $60.58M |
| Cash and Cash Equivalents & Short-Term Investments | $55.63M | $26.85M | $19.66M | $25.94M | $25.94M |
| -Cash and Cash Equivalents | $55.63M | $26.85M | $19.66M | $25.94M | $25.94M |
| Receivables | $26.43M | $24.89M | $13.41M | $11.76M | $11.76M |
| -Accounts Receivable | $26.43M | $24.89M | $13.41M | $11.76M | $11.76M |
| Inventory | $11.08M | $10.14M | $14.47M | $15.42M | $15.42M |
| Other Current Assets | $3.65M | $6.73M | $5.71M | $7.46M | $7.46M |
| Total Non-Current Assets | $60.49M | $47.21M | $44.47M | $31.53M | $31.53M |
| Net PPE | $1.40M | $1.47M | $673,000.00 | $636,000.00 | $636,000.00 |
| -Gross PPE | $1.54M | $1.47M | $673,000.00 | $1.12M | $1.12M |
| -Accumulated Depreciation | -$136,000.00 | – | – | -$486,000.00 | -$486,000.00 |
| Goodwill and Other Intangible Assets | $44.28M | $45.68M | $43.74M | $30.88M | $30.88M |
| Non-Current Deferred Assets | $14.75M | – | – | – | – |
| Other Non-Current Assets | $64,000.00 | $64,000.00 | $54,000.00 | $19,000.00 | $19,000.00 |
| Total Liabilities | $70.35M | $69.22M | $67.10M | $65.96M | $65.96M |
| Total Current Liabilities | $54.10M | $45.12M | $44.18M | $38.49M | $38.49M |
| Payables | $16.50M | $14.41M | $13.49M | $10.98M | $10.98M |
| -Accounts Payable | $16.50M | $14.41M | $13.49M | $10.98M | $10.98M |
| Current Accrued Expenses | $25.75M | $21.89M | $18.89M | $18.73M | $18.73M |
| Short-Term Debt and Capital Lease Obligation | $11.84M | $8.83M | $11.81M | $8.79M | $8.79M |
| -Current Debt | $11.84M | $8.83M | $11.81M | $8.79M | $8.79M |
| Total Non-Current Liabilities | $16.26M | $24.10M | $22.92M | $27.47M | $27.47M |
| Long Term Debt and Capital Lease Obligation | $12.24M | $20.16M | $19.38M | $22.23M | $22.23M |
| -Long Term Debt | $11.23M | $19.08M | $18.94M | $21.77M | $21.77M |
| -Long Term Capital Lease Obligation | $1.02M | $1.08M | $440,000.00 | $460,000.00 | $460,000.00 |
| Other Non-Current Liabilities | $4.01M | $3.94M | $3.54M | $5.24M | $5.24M |
| Total Equity | $86.92M | $46.59M | $30.62M | $26.15M | $26.15M |
| Stockholders' Equity | $86.92M | $46.59M | $30.62M | $26.15M | $26.15M |
| Capital Stock | $29,000.00 | $28,000.00 | $27,000.00 | $27,000.00 | $27,000.00 |
| -Common Stock | $29,000.00 | $28,000.00 | $27,000.00 | $27,000.00 | $27,000.00 |
| Additional Paid-In Capital | $151.01M | $145.92M | $141.53M | $138.62M | $138.62M |
| Retained Earnings | -$64.11M | -$99.36M | -$110.94M | -$112.49M | -$112.49M |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $35.24M | $7.26M | $7.41M | $10.52M | -$11.55M |
| Net cash flow from continuing operations | $35.24M | $7.26M | $7.41M | $10.52M | -$11.55M |
| Net Income from Continuing Operations | $35.25M | $11.58M | $1.55M | -$4.60M | $1.48M |
| Depreciation & Depletion & Amortization | $1.44M | $1.39M | $1.13M | $4.04M | $1.02M |
| Other Non-Cash Items | $3.73M | $839,000.00 | $484,000.00 | $5.83M | $1.61M |
| Change in Working Capital | $4.36M | -$8.37M | $2.49M | -$859,000.00 | -$17.04M |
| -Change in Receivables | -$1.61M | -$11.48M | -$1.65M | -$6.40M | $1.33M |
| -Change in Inventory | -$1.35M | $3.32M | $1.41M | -$5.88M | -$244,000.00 |
| -Change in Prepaid Assets | $3.08M | -$1.02M | $1.75M | -$1.97M | -$2.52M |
| -Change in Payables and Accrued Expense | $5.53M | $2.99M | $2.80M | $10.27M | -$11.57M |
| -Change In Other Working Capital | -$1.30M | -$2.18M | -$1.82M | $3.11M | -$4.03M |
| Net cash flow from investing | -$3.24M | $5,000.00 | -$15.08M | -$333,000.00 | -$49,000.00 |
| Net Cash Flow from Continuing Investing Activities | -$3.24M | $5,000.00 | -$15.08M | -$333,000.00 | -$49,000.00 |
| Net PPE Purchase and Sale | -$13,000.00 | $5,000.00 | -$75,000.00 | -$333,000.00 | -$49,000.00 |
| Net Intangibles Purchase and Sale | -$3.23M | $0.00 | -$15.00M | $0.00 | $0.00 |
| Financing Cash Flow | -$3.22M | -$76,000.00 | $1.39M | $815,000.00 | $421,000.00 |
| Net Cash Flow from Continuing Financing Activities | -$3.22M | -$76,000.00 | $1.39M | $815,000.00 | $421,000.00 |
| Net Issuance Payments Of Debt | -$5.00M | – | – | $0.00 | $0.00 |
| Proceeds from Stock Option Exercised | $1.78M | $2.92M | $1.39M | $815,000.00 | $421,000.00 |
| Ending Cash Balance | $55.63M | $26.85M | $19.66M | $25.94M | $25.94M |
| Net Change in Cash | $28.78M | $7.18M | -$6.28M | $11.01M | -$11.18M |
| Beginning Cash Balance | $26.85M | $19.66M | $25.94M | $14.94M | $37.12M |
| Free Cash Flow | $32.00M | $7.26M | -$7.67M | $10.19M | -$11.60M |
| Net Business Purchase and Sale | – | – | – | $0.00 | – |
| Net Common Stock Issuance | – | – | – | $0.00 | – |
No comments yet — be the first to weigh in on ETON.
Sign in to join the discussion.